Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT04831450 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator Decision

Conditions

Head and Neck Squamous Cell Carcinoma
HNSCC
Squamous Cell Carcinoma of the Larynx
Squamous Cell Carcinoma of the Oral Cavity
Squamous Cell Carcinoma of Hypopharynx

Interventions

DRUG: Cemiplimab-Rwlc

Sponsor

University of Miami

Collaborators

[object Object]